Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice

被引:91
作者
Aggarwal, Pritti [1 ,2 ]
Woolford, Stephen J.
Patel, Harnish P. [3 ,4 ,5 ,6 ]
机构
[1] Southampton City Clin Commissioning Grp, Southampton SO16 4GX, Hants, England
[2] Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Southampton SO17 1BJ, Hants, England
[3] Univ Hosp Southampton NHS FT, Med Older People, Southampton SO16 6YD, Hants, England
[4] Univ Southampton, Acad Geriatr Med, Southampton SO16 6YD, Hants, England
[5] Univ Southampton, NIHR Biomed Res Ctr, Southampton SO16 6YD, Hants, England
[6] Univ Hosp Southampton NHS FT, Southampton SO16 6YD, Hants, England
关键词
multi-morbidity; polypharmacy; comprehensive geriatric assessment; age-friendly care; patient priority care; frailty; deprescribing; RANDOMIZED CONTROLLED-TRIALS; ADVERSE DRUG-REACTIONS; METABOLIC SYNDROME; EXTERNAL VALIDITY; CHRONIC DISEASES; PRIMARY-CARE; MULTIMORBIDITY; PREVALENCE; ADULTS; ADMISSIONS;
D O I
10.3390/geriatrics5040085
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Multi-morbidity and polypharmacy are common in older people and pose a challenge for health and social care systems, especially in the context of global population ageing. They are complex and interrelated concepts in the care of older people that require early detection and patient-centred shared decision making underpinned by multi-disciplinary team-led comprehensive geriatric assessment (CGA) across all health and social care settings. Personalised care plans need to remain responsive and adaptable to the needs and wishes of the patient, enabling the individual to maintain their independence. In this review, we aim to give an up-to-date account of the recognition and management of multi-morbidity and polypharmacy in the older person.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 69 条
  • [1] Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the World Health Surveys
    Afshar, Sara
    Roderick, Paul J.
    Kowal, Paul
    Dimitrov, Borislav D.
    Hill, Allan G.
    [J]. BMC PUBLIC HEALTH, 2015, 15
  • [2] Aiden H., 2018, Multimorbidity: Understanding the challenge (A Report for the Richmond Group of Charities)
  • [3] GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial
    Anderson, Kristen
    Freeman, Christopher
    Foster, Michele
    Scott, Ian
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (02) : 403 - 410
  • [4] [Anonymous], 2013, MAKING IT SAFE SOUND
  • [5] [Anonymous], MULT CLIN ASS MAN
  • [6] A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis
    Avery, Anthony J.
    Rodgers, Sarah
    Cantrill, Judith A.
    Armstrong, Sarah
    Cresswell, Kathrin
    Eden, Martin
    Elliott, Rachel A.
    Howard, Rachel
    Kendrick, Denise
    Morris, Caroline J.
    Prescott, Robin J.
    Swanwick, Glen
    Franklin, Matthew
    Putman, Koen
    Boyd, Matthew
    Sheikh, Aziz
    [J]. LANCET, 2012, 379 (9823) : 1310 - 1319
  • [7] SANRA-a scale for the quality assessment of narrative review articles
    Baethge, Christopher
    Goldbeck-Wood, Sandra
    Mertens, Stephan
    [J]. RESEARCH INTEGRITY AND PEER REVIEW, 2019, 4 (01)
  • [8] Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
    Barnett, Karen
    Mercer, Stewart W.
    Norbury, Michael
    Watt, Graham
    Wyke, Sally
    Guthrie, Bruce
    [J]. LANCET, 2012, 380 (9836) : 37 - 43
  • [9] Polypharmacy - we make it worse! A cross-sectional study from an acute admissions unit
    Betteridge, T. M.
    Frampton, C. M.
    Jardine, D. L.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 (02) : 208 - 211
  • [10] Challenges to physician-patient communication about medication use: a window into the skeptical patient's world
    Bezreh, Tanya
    Laws, M. Barton
    Taubin, Tatiana
    Rifkin, Dena E.
    Wilson, Ira B.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 11 - 18